Cite
HARVARD Citation
Romano, M. et al. (2020). Non‐bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real‐life study. Helicobacter. 25 (4), p. n/a. [Online].